Skip over global navigation links
U.S. Department of Health and Human Services

Preparedness News Releases

  
September 18, 2018: National Biodefense Strategy: Protect the Nation Against all Biological Threats
July 16, 2018: HHS, DoD, Spero co-sponsor novel oral antibiotic development to treat deadly infections
July 13, 2018: Statement by Rick Bright, PhD, Director of ASPR’s Biomedical Advanced Research and Development Authority on the recent FDA approval of TPOXX® as a treatment for smallpox
June 25, 2018: HHS enlists AktiVax to develop improved auto-injector for nerve agent antidotes
June 5, 2018: Seattle-Bellevue company selected to accelerate innovation for U.S. health security, daily medical care
June 5, 2018: Raleigh-Durham company selected to accelerate innovation for U.S. health security, daily medical care
June 5, 2018: Greater Boston company selected to accelerate innovation for U.S. health security, daily medical care
June 5, 2018: Los Angeles company selected to accelerate innovation for U.S. health security, daily medical care
June 5, 2018:New Orleans company selected to accelerate innovation for U.S. health security, daily medical care
June 5, 2018: New York Tristate Area company selected to accelerate innovation for U.S. health security, daily medical care
June 5, 2018: Houston company selected to accelerate innovation for U.S. health security, daily medical care
June 5, 2018: Philadelphia company selected to accelerate innovation for U.S. health security, daily medical care
April 27, 2018: HHS Partners to develop new treatment for seizures caused by nerve agents
April 23, 2018: HHS purchases anthrax antitoxin for Strategic National Stockpile
March 29, 2018: FDA approves Leukine for Acute Radiation Syndrome
October 6, 2017: HHS pursues therapeutic for radiation injury affecting blood platelets
October 6, 2017: HHS sponsors development of drug to treat infections from biowarfare agents, antibiotic-resistant bacteria
October 3, 2017: HHS sponsors development of two tests for radiation exposure
October 3, 2017: HHS, Regeneron partner on portfolio of treatments for pandemic influenza, emerging infectious diseases
October 2, 2017: HHS pursues reusable respirator to better protect medical providers during pandemics
September 29, 2017: HHS accelerates development of first Ebola vaccines and drugs
September 28, 2017: HHS boosts biodefense preparedness with smallpox vaccine for special populations
September 27, 2017: HHS leverages potential respiratory drug as chemical weapon antidote
September 26, 2017: HHS advances point-of-care diagnostic test for anthrax
September 18, 2017: HHS partners to develop first intranasal treatment for cyanide poisoning
September 15, 2017: HHS, Janssen Research & Development join forces on innovative influenza products
September 11, 2017: HHS spurs new antibiotic development for biodefense and common infections
August 29, 2017: FDA approves new antibacterial drug
August 18, 2017: The U.S. Department of Health and Human Services welcomes Robert P. Kadlec, M.D., as Assistant Secretary for Preparedness and Response
July 25, 2017: CARB-X Announces Funding for Global Scientists Racing to Discover New Antibiotics to Treat Superbugs
April 12, 2017: HHS sponsors new Zika diagnostic test, boosting national testing capacity
March 30, 2017: CARB-X injects up to $48 million to accelerate first Powered by CARB-X portfolio of drug discovery and development projects to tackle antibiotic resistance
March 27, 2017: Antimicrobial Resistance Diagnostic Challenge selects 10 semifinalists in first phase of competition
December 12, 2016: Flint by the numbers
November 11, 2016: Assistant Secretary Nicole Lurie announces new BARDA Director
October 6, 2016: HHS enhances nation’s health preparedness for radiological threats
October 5, 2016: HHS pursues tests for radiation absorbed in nuclear emergency
October 4, 2016: HHS sponsors commercial manufacturing tests for Ebola vaccine
October 4, 2016: HHS awards funding to help protect health sector against cyber threats
September 30, 2016: HHS supports next-generation anthrax vaccine into advanced development
September 30, 2016: HHS sponsors next-generation genetic sequencing platform
September 29, 2016: For bioterrorism, HHS sponsors inhaled chlorine antidote
September 26, 2016: BARDA awards funding to speed development of Zika vaccine
September 21, 2016: HHS forges strategic partnerships with two global companies to develop new antibiotics
September 8, 2016: Federal prize competition seeks innovative ideas to combat antimicrobial resistance
September 8, 2016: HHS awards $350,000 to American Academy of Pediatrics to help children affected by the Zika Virus
September 8, 2016: CMS finalizes rule to bolster emergency preparedness of certain facilities participating in Medicare and Medicaid
September 7, 2016: HHS accelerates development of mRNA-based Zika vaccine
September 1, 2016: HHS awards $ 19.8 million to Japanese company to accelerate development of a Zika vaccine
August 25, 2016: HHS funds development of Zika diagnostic test for use in doctors’ offices
1 - 50Next
​​
​​
​​​

Stay Up To Date with PHE.gov

 

Watch, Listen, Subscribe

 
Facebook Exit Icon Twitter Exit Icon YouTube Exit Icon
Email via GovDelivery Exit Icon LinkedIn Exit Icon

  • This page last reviewed: April 26, 2017